Bowker SL - Search Results

1

Self-monitoring in Type 2 diabetes: a randomized trial of reimbursement policy.

Johnson JA, Majumdar SR, Bowker SL, Toth EL, Edwards A. Johnson JA, et al. Among authors: bowker sl. Diabet Med. 2006 Nov;23(11):1247-51. doi: 10.1111/j.1464-5491.2006.01973.x. Diabet Med. 2006. PMID: 17054603 Clinical Trial.

2

Lack of insurance coverage for testing supplies is associated with poorer glycemic control in patients with type 2 diabetes.

Bowker SL, Mitchell CG, Majumdar SR, Toth EL, Johnson JA. Bowker SL, et al. CMAJ. 2004 Jul 6;171(1):39-43. doi: 10.1503/cmaj.1031830. CMAJ. 2004. PMID: 15238494 Free PMC article.

3

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.

Bowker SL, Majumdar SR, Veugelers P, Johnson JA. Bowker SL, et al. Diabetes Care. 2006 Feb;29(2):254-8. doi: 10.2337/diacare.29.02.06.dc05-1558. Diabetes Care. 2006. PMID: 16443869

4

A cross-sectional study of health-related quality of life deficits in individuals with comorbid diabetes and cancer.

Bowker SL, Pohar SL, Johnson JA. Bowker SL, et al. Health Qual Life Outcomes. 2006 Mar 22;4:17. doi: 10.1186/1477-7525-4-17. Health Qual Life Outcomes. 2006. PMID: 16553957 Free PMC article.

5

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Farooki and Schneider.

Bowker SL, Majumdar SR, Veugelers P, Johnson JA. Bowker SL, et al. Diabetes Care. 2006 Aug;29(8):1990-1. doi: 10.2337/dc06-0997. Diabetes Care. 2006. PMID: 16873829 No abstract available.

6

Prospective study of hyperglycemia and cancer risk: response to Stattin et al.

Bowker SL, Johnson JA. Bowker SL, et al. Diabetes Care. 2007 Jul;30(7):e77; author reply e78. doi: 10.2337/dc07-0544. Diabetes Care. 2007. PMID: 17596500 No abstract available.

7

Quality of life after islet transplant: impact of the number of islet infusions and metabolic outcome.

Toso C, Shapiro AM, Bowker S, Dinyari P, Paty B, Ryan EA, Senior P, Johnson JA. Toso C, et al. Transplantation. 2007 Sep 15;84(5):664-6. doi: 10.1097/01.tp.0000280550.01028.89. Transplantation. 2007. PMID: 17876283

8

Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure.

Bowker SL, Yasui Y, Veugelers P, Johnson JA. Bowker SL, et al. Diabetologia. 2010 Aug;53(8):1631-7. doi: 10.1007/s00125-010-1750-8. Epub 2010 Apr 21. Diabetologia. 2010. PMID: 20407744

9

Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials.

Johnson JA, Bowker SL. Johnson JA, et al. Among authors: bowker sl. Diabetologia. 2011 Jan;54(1):25-31. doi: 10.1007/s00125-010-1933-3. Epub 2010 Oct 20. Diabetologia. 2011. PMID: 20959956

10

Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias.

Johnson JA, Bowker SL, Richardson K, Marra CA. Johnson JA, et al. Among authors: bowker sl. Diabetologia. 2011 Sep;54(9):2263-71. doi: 10.1007/s00125-011-2242-1. Epub 2011 Jul 12. Diabetologia. 2011. PMID: 21748485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters